12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Jasco Pharmaceuticals preclinical data

In an animal xenograft model of MM, twice-daily 30 mg/kg oral JP-11646 inhibited tumor growth by 82% vs. vehicle-treated controls. In MM cell...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >